Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Author(s) Date Article Titlesort descending Journal

Omar Abdel-Rahman

 November 2019 ECOG performance score 0 versus 1: impact on efficacy and safety of first-line 5-FU-based chemotherapy among patients with metastatic colorectal cancer included in five randomized trials International Journal of Colorectal Disease

Omar Abdel-Rahman

 December 2019 Effect of Body Mass Index on 5-FU-Based Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer; A Pooled Analysis of 5 Randomized Trials Clinical Colorectal Cancer

S. Peter Wu, Moses Tam, Raymond Mailhot Vega, Carmen A. Perez, Naamit Kurshan Gerber

 November 2017 Effect of Breast Irradiation on Cardiac Disease in Women Enrolled in BCIRG-001 at 10-Year Follow-Up Radiation Oncology

Warit Ruanglertboon, Michael J. Sorich, Andrew Rowland, Ashley M. Hopkins 

 May 2020 Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients International Journal of Clinical Oncology

Eric V.Li, Mohammad R.Siddiqui, Adam B.Weiner, Anna E.Prizment, Charles J.Ryan, Alicia K.Morgans

 March 2021 Efficacy and adverse events of docetaxel for metastatic, hormone-sensitive prostate cancer among elderly men: post-hoc analysis of CHAARTED trial Clinical Genitourinary Cancer

Omar Abdel-Rahman

 October 2019 Efficacy and toxicity outcomes of elderly castrate-resistant prostate cancer patients treated with docetaxel - A pooled analysis of 3 randomized studies Urologic Oncology: Seminars and Original Investigations

Steven B.Cohen, Jennifer Unangst, Feng Yu

 November 2020 Enhancing the analytic utility of clinical trial data to inform health disparities research Contemporary Clinical Trials Communications

Teemu D. Laajala, Mika Murtojārvi, Arho Virkki, Tero Aittokalio

 June 2018 ePCR: An R-package for Survival Time and Time-to-Event Prediction in Advanced Prostate Cancer, Applied to Real-World Patient Cohorts Bioinformatics

Julia Wilkerson, Kald Abdallah, Charles Hugh-Jones, Greg Curt, Mace Rothenberg, Ronit Simantov, Martin Murphy, Joseph Morrell, Joel Beetsch, Daniel J. Sargent, Howard I. Scher, Peter Lebowitz,, Richard Simon, Wilfred D. Stein, Susan E. Bates, Tito Fojo

 January 2017 Estimation of Tumour Regression and Growth Rates During Treatment in Patients with Advanced Prostate Cancer: A Retrospective Analysis The Lancet Oncology

Kelsey H Natsuhara, Li Zhang, Christopher A Carlos, Hala T Borno

 April 2021 Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma: A multi-ethnic cohort study Journal of Onco-Nephrology

Omar Abdel-Rahman, Winson Y. Cheung

 January 2018 External validation of the prostascore model inpatients with metastatic hormone-sensitive prostate cancer recruited to the CHAARTED study BJU International

Timothe Menard, Bjorn Koneswarakantha, Donato Rolo, Yves Barmaz, Leszek Popko, Rich Bowling

 December 2019 Follow‑Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under‑Reporting in Oncology Trials? Drug Safety

Sebastian Pölsterl, Pankaj Gupta, Lichao Wang, Sailesh Conjeti, Amin Katouzian, Nassir Navab

 July 2017 Heterogeneous ensembles for predicting survival of metastatic, castrate-resistant prostate cancer patients F1000 Research

Shalhout, Sophia Z.; Kaufman, Howard L.; Sullivan, Ryan J.; Lawrence, Donald; Miller, David M.

 June 2021 Immune Checkpoint Inhibition in Marjolin Ulcer: A Case Series Journal of Immunotherapy

Pages